Background and objectives Critically ill patients with AKI necessitating renal replacement therapy (RRT) have high in-hospital mortality, and survivors are at risk for kidney dysfunction at hospital discharge. The objective was to evaluate the association between impaired kidney function at hospital discharge with long-term renal and overall survival.
Introduction
Recently, several studies have shown the interplay between AKI, progressive CKD, and long-term mortality (1) (2) (3) (4) (5) (6) . A recent study indicated that even patients who seem to have complete recovery of renal function after AKI have a two-fold increased risk for de novo CKD, which modified the hazard ratio for mortality (7) . These data confirm the notion that AKI is not an innocent event but rather constitutes a significant risk factor for subsequent development of CKD. In addition, the findings are in accordance with the well established association between progressive CKD and increased mortality found in large epidemiologic studies (8) .
Given these data, it is important to identify the risk factors for death and poor renal recovery after AKI in the intensive care unit (ICU). In addition, the factors associated with CKD at hospital discharge and subsequent development of ESRD or death should be studied. Many studies have identified the following as risk factors for increased mortality after AKI: age older than 65 years, elevated Acute Physiology and Chronic Health Evaluation score, associated organ dysfunction, and the need for continuous renal replacement therapy (CRRT) during ICU stay (9) (10) (11) (12) . The need for CRRT during ICU stay is associated with an estimated inhospital mortality between 14% and 60%, depending on the reason for ICU admission and the cause of renal failure (9, 13) . However, our current knowledge about the long-term effects of AKI that necessitates dialysis in critically ill patients after hospital discharge on mortality and renal survival is far from complete. It is clear that incomplete recovery of renal function, specifically dependence on long-term RRT, after an episode of AKI is associated with increased mortality at follow-up (14, 15) . However, definitions of AKI and long-term outcome after an episode of AKI vary among studies, and the degree of kidney function impairment at discharge was not calculated per GFR (6, 12, 16) .
The objective of this study was to evaluate the degree of renal function at hospital discharge as an independent risk factor for long-term renal survival and overall long-term mortality after an episode of AKI that necessitates RRT in the ICU.
Materials and Methods

Setting
A retrospective cohort study was performed in the ICU of a large academic hospital (Erasmus Medical Center, Rotterdam, The Netherlands). All critically ill patients with AKI who required RRT were treated with continuous arteriovenous hemodialysis (30%) or continuous veno-venous hemofiltration. All patients included after 2005 were treated according to the local protocol: Anticoagulation was performed using citrate, unless contraindicated; in that case, heparin was used as an anticoagulant. Before 2005, the standard anticoagulation used was heparin, unless contraindicated. Intermittent hemodialysis was not performed in this group of patients because most patients in our ICU ward were hemodynamically unstable and the ICU lacks facilities to perform intermittent hemodialysis. The study was approved by the medical ethical review board of the Erasmus Medical Center, which waived the requirement of informed consent, because of its retrospective nature.
Study Population and Data Collection
All patients older than 18 years receiving CRRT in the ICU between 1994 and 2010 were included in a database. Patients with RRT or a kidney transplant before ICU admission were excluded from analysis (n=75). Data were collected using the hospital electronic patient registry (EPR). Long-term RRT after hospital discharge was defined as peritoneal dialysis or hemodialysis for more than 3 months or having received a kidney transplant; these data were obtained from the Dutch national RENINE database (RENINE, The Netherlands) or the hospital electronic patient registry. In the population eligible for analysis, the following clinical and demographic data were collected: age, sex, type and date of ICU admission, medical history, duration of ICU admission, cause of AKI, kidney function at discharge, and the need for long-term RRT after discharge. Most patients were mechanically ventilated during their ICU stay; therefore, it was not possible to test the predictive value of mechanical ventilation on outcome.
Definitions
Type of ICU admission was defined as surgical when any surgical procedure was performed in the period before ICU admission. This included abdominal, trauma, transplantation, or thoracic (including cardiac and pulmonary) surgery. Nonsurgical reason for admission included all other admission types, including sepsis, cardiopulmonary resuscitation, cardiac diseases, and intoxication. These are further specified in Table 1 . For medical history we included data on diabetes mellitus; cardiac disease (defined as myocardial infarction before admission, cardiac valvular disease, or heart failure); malignancy; hypertension; cardiac, liver, or lung transplantation; or preexisting CKD. Preexisting CKD was defined as any documented impairment in renal function in the years before ICU admission that did not necessitate long-term RRT or kidney transplant. Because information on kidney function impairment was not available at a standardized preadmission time point and for some patients it was not available at all, we did not attempt to categorize these data according to stage of CKD. Preadmission kidney function was considered normal when the patient had documented normal kidney function at the time of admission or within the previous 2 years, without major events that could have compromised kidney function. Furthermore, we categorized causes of AKI as sepsis, hypotension, and toxic/other. Sepsis was defined as the presence of a systemic inflammatory response with a documented or presumed infection. In the group defined as having AKI caused by hypotension, all prerenal causes were included. All patients with AKI due to toxic drugs, contrast agents, and other nephrotoxic substances were categorized in the "toxic/other" group. Patients who experienced AKI as a result of any other cause (e.g., rhabdomyolysis, vasculitis, or other disorders) were also categorized in this group.
Study Outcomes
The main study outcome measures were overall and renal survival; renal survival was defined as the time until long-term RRT. Survival and the need for long-term RRT are reported at 6 and 12 years after discharge. Furthermore, we evaluated whether degree of kidney dysfunction at discharge was associated with both overall and renal survival. We defined the kidney function at discharge arbitrarily per estimate GFR (eGFR) category using the 
Statistical Analyses
Continuous variables are expressed as median and range. Categorical variables are expressed as number of cases and percentages. Curves for patient survival and renal survival censored for death were generated for each eGFR category by Kaplan-Meier analysis. Log-rank test was used to analyze differences between these curves. Cox regression analysis was used to evaluate independent predictors of long-term mortality. Separate analyses were performed to evaluate changing hazards, for follow-up in the first 90 days and from 90 days to the end of follow-up. Potential risk factors for increased mortality were tested with univariate analysis. When variables were significant in univariate analysis (P,0.05), they were included in a multivariate proportional hazards Cox regression analysis using a multiple forward stepwise approach. Statistical significance was defined by P,0.05. Time-dependent variables were created to evaluate whether hazards were proportionate. Predictive ability of the multivariate proportional hazards model was tested by Harrel C-statistic. Analyses were performed with SPSS software, version 19.0, (SPSS Inc., an IBM company, Chicago, IL).
Results
Clinical Characteristics of RRT-treated ICU Patients Discharged from the Hospital Alive
Between 1994 and 2010, a total of 1220 patients received CRRT in the ICU (Figure 1 ). Seventy-five patients (6%) were known to have received dialysis or have undergone kidney transplantation before hospital admission and were excluded from further analysis. Of the remaining patients, 670 (55%) died in the hospital. Patients alive at hospital discharge (n=475 [39%]) were divided into categories according to their eGFR at discharge (Figure 1 ). Median hospital length of stay was 47 days (range, 2-297 days). More than 60% of the patients had eGFR loss at hospital discharge, of whom 12% needed long-term RRT at this time.
The baseline characteristics of the 475 patients are depicted in Table 1 . The largest group of patients was admitted to the ICU after thoracic surgery, followed by 83 patients admitted for sepsis. Table 1 provides all indications for ICU admission, along with medical history of patients before admission. Preexisting CKD was known in 97 patients (20%), and 229 patients (48%) had normal preadmission kidney function.
Association of Long-term Patient Survival with eGFR at Hospital Discharge
Follow-up after hospital discharge varied from 1 to 17 years, with a median follow-up of 8.5 years. Survival rates for patients alive at hospital discharge at 6 years and 12 years were 62% and 44%, respectively. Cumulative survival per category was determined by Kaplan-Meier analysis (Figure 2) . A log-rank test comparing all categories showed a significant difference in patient long-term survival (P,0.001 Table 2 . Most of the patients discharged with an eGFR ,15 ml/min per 1.73 m 2 experienced acute-on-chronic kidney injury (56% of patients in this category had preexisting CKD).
Univariate analysis identified several clinical variables associated with worse long-term patient survival, as shown in Table 3 . Age, date of ICU admission, nonsurgical reason for ICU admission, malignancy, and eGFR ,30 ml/min per 1.73m 2 at hospital discharge remained significantly associated with patient survival after multivariate proportional hazards analysis (Table 3) . Separate analysis for the first 90 days after discharge and from 90 days until the end of follow-up showed that hazards were proportionate during follow-up. The predictive ability of this multivariate proportional hazards model was tested by Harrel C-statistics. We found a concordance of 0.69 (SEM, 0.02).
Association of eGFR at Hospital Discharge with Renal Survival
Renal survival rates after hospital discharge at 6 and 12 years were 83% and 74%, respectively. Comparing renal survival censored for death showed an overall significant difference between eGFR categories (P,0.001) (Figure 3 . The unadjusted 6-and 12-year renal survival censored for death per eGFR category shows the association between an increased incidence of initiation of RRT and impaired eGFR at hospital discharge (Table 2) .
After multivariate proportional hazards analysis, the following variables were strongly associated with decreased renal survival: preexisting CKD (compared with patients with documented normal prior kidney function) and an eGFR ,30 ml/min per 1.73 m 2 at hospital discharge (Table 4) . Hazards were proportionate during follow-up.
The results show that an eGFR ,30 ml/min per 1.73 m 2 at hospital discharge is an independent and strong predictor of poor long-term renal survival. The predictive ability of this multivariate proportional hazards model was tested by Harrel C-statistics. We found a concordance of 0.96 (SEM, 0.03).
Discussion
The results of this study show that after an episode of AKI necessitating RRT in the ICU, long-term survival and renal survival were both strongly related to the degree of kidney function impairment at hospital discharge. In particular, an eGFR ,30 ml/min per 1.73 m 2 is an independent predictor of death and worse renal survival at long-term follow-up. About a third of all patients who survive their ICU stay and leave the hospital are discharged with an eGFR ,30 ml/min per 1.73 m 2 . In addition, the majority of patients in our cohort (.60%) had impaired kidney function at hospital discharge. Therefore, our findings are clinically relevant because they indicate that most of the patients who have received RRT in the ICU are at risk for CKD and, therefore, further deterioration of kidney function and increased mortality in the years thereafter.
A recently published large systematic review evaluated 15 studies on long-term mortality after an episode of AKI defined by different criteria in different patient populations. Remarkably, none of these studies had patient follow-up as long as or a cohort as diverse as in our study (17) . Overall, it is apparent that an episode of AKI with or without the need for RRT is independently associated with an increased risk (relative risk, 1.6-3.9) for death at followup. A meta-analysis performed on 13 cohort studies evaluated the association of AKI with the risk of developing CKD. The results showed that AKI was a strong independent risk factor for development of CKD (HR, 8.8) and ESRD (HR, 3.1) (18) .
Some studies have described the relation between impaired kidney function at hospital discharge and long-term survival. In a study performed by Liaño et al., patients with complete renal recovery after an episode of AKI were compared with patients who had only partial recovery. Data are given as percentages of initial number of patients alive (overall survival) or without renal replacement therapy (renal survival) at 6 years and 12 years stratified per category at hospital discharge. Variables tested in multivariate analysis: age, medical admission type, preexisting CKD, admission diagnosis sepsis, thoracic surgery or other, class of estimated GFR at discharge, malignancy, cardiovascular disease, diabetes mellitus, hypertension, and year of admission. HR, hazard ratio; CI, confidence interval; eGFR, estimated GFR (categorical class at discharge, compared with eGFR $60 ml/ min per 1.73 m 2 ). Survival was worse in the latter group. However, the degree of renal insufficiency at discharge was not shown, and the study included patients who developed AKI but were not admitted to an ICU or treated with RRT (19) . Only a few studies have evaluated the mortality rate and renal survival of patients who received RRT in the ICU after their hospital discharge (6, (20) (21) (22) . The largest study population was described by Wald et al. and consisted of 3769 patients enrolled during a 10-year period; the patients were compared with matched control ICU patients without AKI or RRT (6) . The AKI group had a significantly increased risk for long-term RRT (HR, 3.23), but overall survival (50% mortality after 8 years) was similar to that in the control ICU patient group. In our study, patients discharged with an eGFR ,30 ml/min per 1.73 m 2 (including patients receiving long-term RRT) showed a persistent association with long-term mortality after multivariate analysis. Only one published study is similar in design to ours (14) ; that study followed 226 survivors of RRT in the ICU for 5 years. Cumulative survival at 5 years was 47%, and partial recovery of renal function after RRT in the ICU was an independent predictor of poor long-term survival.
Of interest is the lack of association of cardiovascular risk factors, such as hypertension and diabetes mellitus, with survival and between preexisting CKD and survival. The significance of these relationships was lost in the multivariate analysis in which age and ESRD were the major risk factors for decreased survival. In the large cohort evaluated by Wald et al., patients who needed RRT during the first 30 days after hospital discharge were excluded from analysis (6) . According to our results, this would be the group of patients with worse long-term survival and could therefore at least partly explain the lack of association with mortality in their study. It is possible that some degree of renal recovery may still take place after hospital discharge, leading to underestimation of the true rate of renal recovery; unfortunately, data on renal recovery after hospital discharge were not available in our cohort (14, 23) .
We cannot conclude with certainty that the association between an eGFR ,30 ml/min per 1.73 m 2 at hospital discharge and worse long-term survival implies causality. However, the association persisted even after adjustment for possible covariates that included known risk factors for CKD and progression of CKD, such as age and cardiovascular risk factors and preexisting CKD. Many studies have consistently shown that patients developing ESRD are at higher risk for cardiovascular events and have a higher mortality risk (8, 24, 25) . All these observations agree with data from the general population in which mortality risk exponentially increases when GFR decreases below 60 ml/ min per 1.73 m 2 (8) . Therefore, prevention of (further) renal function deterioration in patients experiencing AKI by avoiding nephrotoxic drugs as much as possible could improve overall survival and prevent patients from reaching ESRD. Long-term nephrologic follow-up is necessary for patients who experience incomplete renal recovery after an episode of AKI, especially patients discharged with an eGFR ,30 ml/min per 1.73 m 2 , to minimize the complications of CKD.
Limitations of our study include its retrospective singlecenter cohort design. We did not calculate GFR by inulin clearance or a 24-hour urine collection but rather used eGFR according to the MDRD formula. Although this formula considers sex and age, it cannot correct for changes in body composition, as may be expected in formerly critically ill patients. However, because a substantial loss of muscle mass has most likely occurred in ICU patients, the eGFR at hospital discharge probably overestimates the true GFR and subsequently underestimates the number of patients discharged with an eGFR ,30 ml/min per 1.73 m 2 . Therefore, the effect of eGFR loss may be even greater than recorded in this study. On the other hand, follow-up of kidney function after discharge is not available in our cohort, and some patients may have shown a variable degree of recovery of eGFR over time that we could not account for in our analysis.
Because of the large time span of our patient registry, we depended on the analog and digital patient data management systems that have been used over time. Organ failure scores are available only since 2005 and have not always been used in our ICU; unfortunately, it is not possible to analyze the influence of severity of illness on overall and renal survival. In addition, treatment modalities for RRT and overall treatment strategies for ICU patients have changed over time. Date of admission was therefore included in our multivariate analyses but did not affect the overall conclusions.
The in-hospital mortality rate (55%) in our cohort, the percentage of patients discharged with the need for longterm RRT, and the overall survival of our patients after hospital discharge are similar to the results of previous studies (12, 14, (26) (27) (28) (29) . Furthermore, our cohort contains a diverse population of ICU patients, including a large group of patients admitted after thoracic surgery and septic patients. We found no differences in survival between admission types after multivariate analysis. Therefore, the patients in our cohort seem to represent an average population of ICU patients.
These findings add credibility to the generalization of our major finding that impaired kidney function at hospital discharge is independently associated with worse longterm overall and renal survival.
